Sales EmailTemplate

Pharmaceuticals · Sales VP · Long Time No Contact

Referral Request for Pharmaceuticals Sales VP: Long Time No…

A referral request email for a Pharmaceuticals Sales VP (long time no contact) is a short message that reopens the thread without making them do extra work. A referral request email asks someone to make an intro by doing the work for them: who, why, and a forwardable blurb. In this setting, that means speaking to follow-up that ignores MLR,

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this referral request work for a Pharmaceuticals Sales VP?

  • Explain why they'd look good for making the intro.
  • Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
  • Fits how a sales VP actually reads: 70 to 90 words. Lead with the outcome.
  • Bring a new observation about their world, then offer a small, optional next step.
  • Include a forwardable paragraph.

When should I send this to a Pharmaceuticals Sales VP?

Ask after you've given them a reason to want to help, not after the first coffee. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a sales VP, 70 to 90 words. Lead with the outcome.

What this Sales VP actually cares about

A sales VP in Pharmaceuticals is protecting quota, forecast credibility, and rep time. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby. The hook that earns a look is a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem. The ask should stay at this size: a 15-minute look at one metric, not a platform tour. Delete trigger: Telling them how to sell. They've heard it. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby.

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. If you cannot name a label update, a launch window, or a congress, wait until you can. If you cannot name a label update, a launch window, or a congress, wait until you can.

How should I customize this template before I send it?

  • Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
  • Keep the tone crisp and commercial.
  • Never send a referral ask from a brand-new relationship.
  • Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
  • Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this long time no contact note?

  • Asking 'who do you know?' is lazy and gets no names.
  • Don't open with 'it's been a while' and then paste the old pitch.
  • Don't use consumer-startup slang. It's a credibility leak.
  • Telling them how to sell. They've heard it.

How does this long time no contact scenario compare?

DimensionFor this template
Best send windowOnly when you have a trigger
Ideal length70 to 90 words. Lead with the outcome.
Primary aska 15-minute look at one metric, not a platform tour
Industry metric to citetime through MLR, access, and compliant engagement rates
ToneCrisp and commercial. They can handle a direct ask.
Unlike no responseThis isn't a 4-day bump. It's a re-introduction with a new reason.
Unlike breakupYou're opening a door, not closing one. Still keep it easy to ignore.

What should I copy and send?

Copy-ready template

Subject

Forwardable blurb inside, if you're open to an intro

Body

Hi [First Name],

This is an ask. I tried to make it easy to say no.

I'm writing because a label update, a launch window, or a congress. Blurb you can paste: '[Your Name] helps [audience] with cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. They asked if you'd be open to a short intro about [topic].'

Re-earn a conversation, not restart a stale sequence at email 4.

Thanks either way. I know intros cost you something.

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

No. Unapproved claims, off-label hints, and fake urgency can create real problems. Be operational: timelines, review status, access, meeting logistics. Save clinical discussion for approved materials and the right role. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Related templates

Want a custom draft instead? Try the email generator.